布鲁顿的氨酸激酶:神经疾病的一个潜在的新目标
1Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. danica.michalickova@lf1.cuni.cz; Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. ondrej.slanar@lf1.cuni.cz.
Physiological research
|May 28, 2025
概括
布鲁顿氨酸激酶 (BTK) 在大脑炎症和阿尔茨海默氏症等神经系统疾病中起着关键作用. 抑制BTK可能为这些疾病提供新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 布鲁顿的氨酸激酶 (BTK) 是B细胞受体信号传递的组成部分,并具有超出癌症的作用.
- 新兴的研究强调了BTK在神经系统疾病和大脑代谢中的参与.
- 炎症酶激活,特别是NLRP3,是将BTK与神经炎症联系起来的关键机制.
研究的目的:
- 探索BTK在各种大脑疾病中被低估的作用.
- 讨论BTK抑制在神经疾病中的治疗潜力.
主要方法:
- 文献综述和关于神经疾病中BTK的当前研究的综合.
- 分析BTK在炎症酶激活和神经炎症中的作用.
主要成果:
- BTK与多发性硬化症,阿尔茨海默病和脑损伤的病理生理学有关.
- 比特基激活通过炎症酶促进与年龄相关的和与疾病相关的神经炎症.
- 抑制BTK是一种治疗神经系统疾病的有希望的途径.
结论:
- BTK是神经系统疾病发病的一个重要因素.
- 针对BTK为一系列大脑疾病提供了潜在的治疗策略.
更多相关视频
相关概念视频
Enzyme-linked Receptors
77.5K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.5K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Receptor Tyrosine Kinases
12.4K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.4K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
The Blood-brain Barrier
47.0K
Overview
47.0K
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K


